Dr Reddy’s Laboratories (RDY) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Reddy’s Laboratories has expanded its global footprint by establishing a new wholly-owned subsidiary, Dr. Reddy’s Denmark ApS, in Denmark. This strategic move, aligning with the company’s main pharmaceutical and biotechnological business, involves the subsidiary promoting production and related activities in Denmark. The cash-funded acquisition makes Dr. Reddy’s Denmark ApS a step-down subsidiary of the parent company.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.